TTOO OTC
T2 Biosystems, Inc.
1W: +20.0%
1M: -40.0%
3M: -70.0%
YTD: -88.0%
1Y: -95.1%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$48M
+4.9% ▲
Capital Expenditures
$192K
+43.4% ▲
5Y CAGR: -20.2%
Free Cash Flow
-$48M
+5.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$4M
+136.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$59M | -$47M | -$49M | -$62M | -$50M |
| Depreciation & Amort. | $4M | $3M | $3M | $2M | $859K |
| Stock-Based Comp. | $5M | $4M | $7M | $6M | $4M |
| Change in Working Capital | $2M | -$7M | -$2M | -$503K | -$4M |
| Other Non-Cash Items | $2M | $3M | $4M | $3M | $773K |
| Operating Cash Flow | -$45M | -$43M | -$39M | -$51M | -$48M |
| — Investing Activities — | |||||
| Capital Expenditures | -$761K | -$804K | -$460K | -$339K | -$192K |
| Acquisitions (Net) | $0 | $4K | $0 | $0 | $0 |
| Investment Purchases | $0 | -$51M | $0 | $0 | $0 |
| Investment Sales | $0 | $15M | $25M | $10M | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$761K | -$36M | $25M | $10M | -$192K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$882K | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | -$330K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $582K | $296K | $567K | -$78K | -$43K |
| Financing Cash Flow | $6M | $86M | $21M | $29M | $53M |
| Net Change in Cash | -$40M | $6M | $6M | -$12M | $4M |
| Cash End of Period | $11M | $17M | $24M | $12M | $16M |
| Free Cash Flow | -$46M | -$44M | -$39M | -$51M | -$48M |